Lost Money on GSK plc(GSK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action securities lawsuit against GSK plc, alleging the company misled investors about Zantac's potential cancer risks between February 2020 and August 2022. The lawsuit claims GSK knew about NDMA sources for decades but did not disclose this information to shareholders, potentially causing financial losses.
March 20, 2025 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The lawsuit alleges GSK misled investors about Zantac's cancer risks, which could result in significant legal and financial consequences for the company.
The class action lawsuit directly targets GSK's alleged securities fraud, which could lead to financial penalties, legal costs, and potential reputational damage. The lawsuit's claims about long-term knowledge of NDMA risks may negatively impact investor confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100